103 related articles for article (PubMed ID: 14553825)
1. Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes.
Lyngdorf LG; Gregersen S; Daugherty A; Falk E
Cardiovasc Res; 2003 Oct; 59(4):854-62. PubMed ID: 14553825
[TBL] [Abstract][Full Text] [Related]
2. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.
Boord JB; Maeda K; Makowski L; Babaev VR; Fazio S; Linton MF; Hotamisligil GS
Circulation; 2004 Sep; 110(11):1492-8. PubMed ID: 15353487
[TBL] [Abstract][Full Text] [Related]
3. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.
Fujii A; Allen TJ; Nestel PJ
Atherosclerosis; 2007 Jul; 193(1):55-61. PubMed ID: 16996521
[TBL] [Abstract][Full Text] [Related]
4. Insulin response to a spontaneously ingested standard meal during the development of obesity in GTG-injected mice.
Blair SC; Caterson ID; Cooney GJ
Int J Obes Relat Metab Disord; 1996 Apr; 20(4):319-23. PubMed ID: 8680458
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes.
Shirakami A; Toyonaga T; Tsuruzoe K; Shirotani T; Matsumoto K; Yoshizato K; Kawashima J; Hirashima Y; Miyamura N; Kahn CR; Araki E
J Endocrinol; 2002 Aug; 174(2):309-19. PubMed ID: 12176670
[TBL] [Abstract][Full Text] [Related]
6. Increased gluconeogenesis in hepatocytes from GTG-obese mice is insensitive to inhibition by insulin.
Greenaway TM; Cooney GJ; Blair SC; Caterson ID
Int J Obes Relat Metab Disord; 1992 Dec; 16(12):985-90. PubMed ID: 1335978
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.
Kawashima Y; Chen J; Sun H; Lann D; Hajjar RJ; Yakar S; Leroith D
Diabetologia; 2009 Jul; 52(7):1434-41. PubMed ID: 19436992
[TBL] [Abstract][Full Text] [Related]
8. Glucose tolerance and insulin secretion after adrenalectomy in mice made obese with gold thioglucose.
Blair SC; Caterson ID; Cooney GJ
J Endocrinol; 1996 Mar; 148(3):391-8. PubMed ID: 8778217
[TBL] [Abstract][Full Text] [Related]
9. Changes in glycogen metabolism in liver of gold thioglucose injected mice during the development of obesity.
Chen C; Williams PF; Cooney GJ; Caterson ID
Int J Obes Relat Metab Disord; 1994 Sep; 18(9):627-31. PubMed ID: 7812417
[TBL] [Abstract][Full Text] [Related]
10. Effect of adrenalectomy on glucose tolerance and lipid metabolism in gold-thioglucose obese mice.
Blair SC; Caterson ID; Cooney GJ
Am J Physiol; 1994 Jun; 266(6 Pt 1):E993-1000. PubMed ID: 8023932
[TBL] [Abstract][Full Text] [Related]
11. Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test.
Martins IJ; Tran JM; Redgrave TG
J Nutr; 2002 Feb; 132(2):176-81. PubMed ID: 11823575
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice.
Ventre J; Doebber T; Wu M; MacNaul K; Stevens K; Pasparakis M; Kollias G; Moller DE
Diabetes; 1997 Sep; 46(9):1526-31. PubMed ID: 9287059
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of mazindol in preventing onset and development of obesity induced by gold thioglucose injection.
Kawano-Takahashi Y; Ohminaji H; Ubagai E; Okuda H
Int J Obes; 1984; 8(6):655-64. PubMed ID: 6442712
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of BRL 26830A for 9 weeks improves insulin sensitivity but does not prevent weight gain in gold-thioglucose obese mice.
Bryson JM; Wensley VR; Phuyal JL; Caterson ID; Cooney GJ
Horm Metab Res; 1999 May; 31(5):317-22. PubMed ID: 10422727
[TBL] [Abstract][Full Text] [Related]
15. Obesity-induced diabetes in mouse strains treated with gold thioglucose: a novel animal model for studying β-cell dysfunction.
Karasawa H; Takaishi K; Kumagae Y
Obesity (Silver Spring); 2011 Mar; 19(3):514-21. PubMed ID: 20706204
[TBL] [Abstract][Full Text] [Related]
16. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
17. Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice.
Lin RY; Choudhury RP; Cai W; Lu M; Fallon JT; Fisher EA; Vlassara H
Atherosclerosis; 2003 Jun; 168(2):213-20. PubMed ID: 12801603
[TBL] [Abstract][Full Text] [Related]
18. Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E.
Hirano T; Takahashi T; Saito S; Tajima H; Ebara T; Adachi M
Am J Physiol Endocrinol Metab; 2001 Oct; 281(4):E665-9. PubMed ID: 11551841
[TBL] [Abstract][Full Text] [Related]
19. Changes in the lipogenic response to feeding of liver, white adipose tissue and brown adipose tissue during the development of obesity in the gold-thioglucose-injected mouse.
Cooney GJ; Vanner MA; Nicks JL; Williams PF; Caterson ID
Biochem J; 1989 May; 259(3):651-7. PubMed ID: 2499313
[TBL] [Abstract][Full Text] [Related]
20. [In vitro and in vivo effect of gold thioglucose on the insulin- and glucagon-secretion of the isolated perfused rat pancreas].
Blech W; Bierwolf B; Weiss I; Ziegler M
Biomed Biochim Acta; 1986; 45(4):507-22. PubMed ID: 3085662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
